Research output per year
Research output per year
Personal profile
Education/Academic qualification
Biological Sciences, Doctorate, Functional and Structural Studies on Escherichia coli RNase II: a crucial enzyme in RNA metabolism, Instituto de Tecnologia Química e Biológica António Xavier (ITQB)
1 Sept 2003 → 14 Dec 2007
Award Date: 14 Dec 2007
External positions
Instituto de Biologia Experimental e Tecnológica (IBET)
1 Nov 2009 → 31 Dec 2014
Fingerprint
Dive into the research topics where Ana Barbas is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Development of Dl1.72, a novel anti-DLL1 antibody with anti-tumor efficacy against estrogen receptor-positive breast cancer
Silva, G., Sales-Dias, J., Casal, D. B., Alves, S., Domenici, G., Barreto, C., Matos, C., Lemos, A. R., Matias, A. T., Kucheryava, K., Ferreira, A., Moita, M. R., Braga, S., Brito, C., Cabral, M. G., Casalou, C., Barral, D. C., Sousa, P. M. F., Videira, P. A., Bandeiras, T. M., & 1 others, 2 Aug 2021, In: Cancers. 13, 16, 4074.Research output: Contribution to journal › Article › peer-review
Open AccessFile6 Citations (Scopus)47 Downloads (Pure) -
Evaluation of AAV-mediated delivery of shRNA to target basal-like breast cancer genetic vulnerabilities
Pinto, C., Silva, G., Ribeiro, A. S., Oliveira, M., Garrido, M., Bandeira, V. S., Nascimento, A., Coroadinha, A. S., Peixoto, C., Barbas, A., Paredes, J., Brito, C. & Alves, P. M., 20 Jul 2019, In: Journal of Biotechnology. 300, p. 70-77 8 p.Research output: Contribution to journal › Article › peer-review
16 Citations (Scopus) -
The Notch ligand DLL1 exerts carcinogenic features in human breast cancer cells
Sales-Dias, J., Silva, G., Lamy, M., Ferreira, A. & Barbas, A., 1 May 2019, In: PLoS ONE. 14, 5, e0217002.Research output: Contribution to journal › Article › peer-review
Open AccessFile16 Citations (Scopus)70 Downloads (Pure) -
Antigenic response to CT-P13 and infliximab originator in inflammatory bowel disease patients shows similar epitope recognition
Goncalves, J., Santos, M., Acurcio, R., Iria, I., Gouveia, L., Matos Brito, P., Catarina Cunha-Santos, A., Barbas, A., Galvão, J., Barbosa, I., Aires da Silva, F., Alcobia, A., Cavaco, M., Cardoso, M., Delgado Alves, J., Carey, J. J., Dörner, T., Eurico Fonseca, J., Palmela, C., Torres, J., & 12 others, Sept 2018, In: Alimentary Pharmacology and Therapeutics. 48, 5, p. 507-522 16 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile22 Citations (Scopus)7 Downloads (Pure) -
Novel monoclonal antibody L2A5 specifically targeting sialyl-Tn and short glycans terminated by alpha-2–6 sialic acids
Loureiro, L. R., Sousa, D. P., Ferreira, D., Chai, W., Lima, L. C. O., Pereira, C., Lopes, C. B., Correia, V. G., Silva, L. M., Li, C., Santos, L. L., Ferreira, J. A., Barbas, A., Palma, A. S., Novo, C. & Videira, P. A., 1 Dec 2018, In: Scientific Reports. 8, 1, 12196.Research output: Contribution to journal › Article › peer-review
Open AccessFile40 Citations (Scopus)67 Downloads (Pure)
Prizes
-
Therapeutic targets for triple negative breast cancer: development of mono and bispecific antibodies against Notch1 ligands
Barbas, Ana (Recipient) & Videira, Paula Alexandra (Recipient), 1 Jan 2016
Prize: Fellowship awarded competitively